Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.80
Delayed Data
As of Jun 24
 -1.76 / -4.14%
Today’s Change
36.71
Today|||52-Week Range
44.85
+2.56%
Year-to-Date
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
New Stock Research Reports for June 21, 2016
Jun 21 / Zacks.com - Paid Partner Content
Jeff Auxier Sells Precision Castparts, AT&T, Microsoft
Jun 23 / GuruFocus News - Paid Partner Content
Glaxo/Innoviva's Closed Triple Combination Tops Phase III
Jun 21 / Zacks.com - Paid Partner Content
GlaxoSmithKline Has No Cure for Sideways Action
Jun 23 / TheStreet.com - Paid Partner Content
How Inovio Pharmaceuticals Is Leading the Zika Vaccine Race
Jun 21 / MotleyFool.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
What To Hold: 3 Hold-Rated Dividend Stocks SEAS, SIR, GSK
Jun 20 / TheStreet.com - Paid Partner Content
Zika vaccine maker's stock is on fire
Jun 22 / CNNMoney.com
GlaxoSmithKline (GSK) Leads The Pack In Pre-Market Activity
Jun 20 / TheStreet.com - Paid Partner Content
Can These Upstarts Knock Gilead Sciences Off Its Perch?
Jun 22 / MotleyFool.com - Paid Partner Content
3 Reasons Gilead Sciences Is a Buy
Jun 17 / MotleyFool.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Jun 15 / MotleyFool.com - Paid Partner Content